Table 1 Physical and biochemical findings in blood plasma amongst different experimental groups.

From: FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis

 

TAA (n = 8)

TAA + OCA (n = 9)

P-value

TAA + 4 (n = 6)

TAA + 4 + OCA (n = 9)

P-value

Body weight (g)

319 ± 11

302 ± 11

0.27

395 ± 9

410 ± 12

0.38

Overall average dose TAA (g/L)

520 ± 13

478 ± 23

0.15

478 ± 19

450 ± 21

0.31

Liver weight

22 ± 2

22 ± 2

0.89

24 ± 2

22 ± 2

0.32

Albumin (g/L)

33.5 ± 0.8

35.1 ± 1.2

0.28

35.2 ± 1.0

36.6 ± 0.7

0.45

AST (IU/L)

85 ± 4

87 ± 7

0.76

100 ± 4

93 ± 4

0.68

ALT (IU/L)

75 ± 4

66 ± 3

0.34

97 ± 4

79 ± 4

*0.01

Bilirubin (mg/dL)

0.3 ± 0.1

0.3 ± 0.2

0.92

0.0 ± 0.0

0.0 ± 0.1

0.90

  1. TAA, thioacetamide; OCA, obeticholic acid; AST, aspartate aminotransferase; ALT, alanine aminotransferase.